Serine/threonine kinase 31 promotes PDCD5-mediated apoptosis in p53-dependent human colon cancer cells

Journal of Cellular Physiology
Sungmin KwakKyung-Chul Choi

Abstract

Although programed cell death 5 (PDCD5) is an important protein in p53-mediated proapoptotic signaling, very little is known about PDCD5-related cell death. In this study, we report that serine/threonine kinase 31 (STK31) interacts with PDCD5, which maintains the stability of PDCD5. STK31 overexpression significantly activated PDCD5 stabilization and p53-mediated apoptosis in response to etoposide (ET). However, STK31 knockdown did not enhance apoptosis by ET treatment. Moreover, when STK31 was depleted, PDCD5 inhibited the activation of the p53 signaling pathway with ET, indicating that the PDCD5-STK31 network has an essential role in p53 activation. Importantly, STK31 activated the p53 signaling pathway by genotoxic stress through positive regulation of PDCD5-mediated apoptosis. We thus demonstrated that overexpression of STK31 greatly inhibited tumorigenic growth and increased the chemosensitivity of HCT116 human colorectal carcinoma cells. Taken together, these findings demonstrate that the STK31-PDCD5 complex network regulates apoptosis of cancer cells, and STK31 is a positive apoptosis regulator that inhibits tumorigenesis of colon cancer cells by inducing PDCD5-mediated apoptosis in response to genotoxic stress.

References

May 15, 1997·Nature·M H KubbutatK H Vousden
Aug 28, 1998·Science·G Evan, T Littlewood
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·R R Wallace-Brodeur, S W Lowe
Feb 26, 2000·Carcinogenesis·S W Lowe, A W Lin
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·C J Norbury, I D Hickson
Mar 26, 2003·Cell·Roger P LengSamuel Benchimol
Apr 23, 2004·Nature·David DornanVishva M Dixit
Oct 29, 2004·Nature Reviews. Cancer·Ann M Bode, Zigang Dong
Dec 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·L N ChenY Y Chen
Mar 21, 2006·Apoptosis : an International Journal on Programmed Cell Death·Y-H YangY-Y Lu
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monica SpinolaAndreas Braun
Apr 1, 2006·Cell Death and Differentiation·O Laptenko, C Prives
Feb 5, 2008·Molecular Reproduction and Development·Khalida SabeurAlan Conley
Mar 25, 2009·Neoplasia : an International Journal for Oncology Research·Lanjun XuDalong Ma
Mar 30, 2010·Apoptosis : an International Journal on Programmed Cell Death·Changbao ChenYingyu Chen
Sep 28, 2010·Journal of Surgical Oncology·Changbao ChenQingjun Ma
Jul 26, 2012·Carcinogenesis·Kin Lam FokHsiao Chang Chan
Aug 24, 2012·Apoptosis : an International Journal on Programmed Cell Death·Lanjun XuYingyu Chen

❮ Previous
Next ❯

Citations

Apr 3, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Dmitry ProkopenkoRudolph E Tanzi
Jun 30, 2021·Journal of Occupational and Environmental Medicine·Feizai HaTiancheng Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.